Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNovacyt Regulatory News (NCYT)

Share Price Information for Novacyt (NCYT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.00
Bid: 68.00
Ask: 70.00
Change: 0.90 (1.32%)
Spread: 2.00 (2.941%)
Open: 68.00
High: 68.60
Low: 68.00
Prev. Close: 68.10
NCYT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Yourgene Health plc

8 Sep 2023 12:00

RNS Number : 8668L
Stifel Nicolaus Europe Limited
08 September 2023
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Stifel Nicolaus Europe Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Yourgene Health plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Yourgene Health plc

(d) Date dealing undertaken:

07 September 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary

Buy

587,379

0.5126 GBX

0.5126 GBX

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

Date of disclosure:

08 September 2023

Contact name:

Jordan Gaskell

Telephone number:

0207 710 7482

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEREAPNPEFLDEEA
Date   Source Headline
23rd Apr 20247:00 amRNSLong Term Incentive Plan
19th Apr 20247:00 amRNSDHSC Claim update – Pre-Trial Review
11th Apr 20247:00 amRNSDirectorate Changes and FY 23 results update
2nd Apr 20244:00 pmRNSLiquidity Agreement and Total Voting Rights
1st Mar 202412:30 pmRNSLiquidity Agreement and Total Voting Rights
6th Feb 20247:00 amRNSUpdate on Taiwanese divestment
1st Feb 20241:00 pmRNSLiquidity Agreement and Total Voting Rights
25th Jan 20247:00 amRNSTrading update
3rd Jan 202411:00 amRNSLiquidity Agreement and Total Voting Rights
2nd Jan 20247:00 amRNSAppointment of CFO
21st Dec 20237:00 amRNSUpdate on Taiwan laboratory disposal
1st Dec 202311:45 amRNSLiquidity Agreement and Total Voting Rights
7th Nov 20237:00 amRNSIVDR certification for DPYD genotyping assay
1st Nov 20232:30 pmRNSLiquidity Agreement and Total Voting Rights
26th Oct 20233:20 pmRNSResult of AGM
11th Oct 20237:00 amRNSAGM voting
5th Oct 20232:15 pmRNSNotice of rescheduled AGM
2nd Oct 20231:30 pmRNSLiquidity Agreement and Total Voting Rights
28th Sep 20233:15 pmRNSReminder to shareholders re. AGM voting
28th Sep 20237:00 amRNS2023 Interim Results
14th Sep 20237:00 amRNSAGM voting
13th Sep 20237:00 amRNSNotice of Results
11th Sep 20237:55 amRNSCancellation of trading of Yourgene Shares
8th Sep 202312:00 pmRNSCompletion of acquisition of Yourgene Health plc
8th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
7th Sep 202312:22 pmRNSCourt sanction of the Scheme of Arrangement
1st Sep 202312:30 pmRNSLiquidity Agreement and Total Voting Rights
29th Aug 20237:00 amRNSNotice of rescheduled AGM
17th Aug 20235:16 pmRNSAcquisition update
1st Aug 202311:45 amRNSLiquidity Agreement and Total Voting Rights
27th Jul 20237:00 amRNSHalf Year Trading Update
19th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
18th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
17th Jul 202312:00 pmRNSForm 8.5 (EPT/RI)
14th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
13th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
13th Jul 20237:00 amRNSNotice of cancelled AGM
12th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
11th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
10th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
7th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
6th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
5th Jul 20231:27 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc Amended
5th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
4th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
3rd Jul 202312:00 pmRNSLiquidity Agreement and Total Voting Rights
3rd Jul 20237:01 amRNSRecommended cash offer for Yourgene Health plc
15th Jun 20234:00 pmRNSNotice of rescheduled AGM
12th Jun 20237:00 amRNSReminder to shareholders re. AGM voting
1st Jun 20231:00 pmRNSLiquidity Agreement and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.